- Turnover Increased by 54.9% YoY to HK$209.4 million
- Recording EBITDA of HK$28.4 million
- Achieved Significant Progress towards Pipeline Product with 2 Product Launches Expected in 2020
HONG KONG, CHINA - EQS Newswire - 1 April 2020 - A fully integrated biopharmaceutical company -- Uni-Bio Science Group Limited ("Uni-Bio Science", together with...
More...